FineHeart

Our mission is to address the unmet need of patients with sever heart failure

Health and bio

TIMELINE · MONEY RAISED

FineHeart | 3887 days on the record

Raised $122M in 3 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. January 9, 2026
   Series B+ · $96.9M
   GGroupe Pasteur Mutualité (lead), DDoliam, EEuropean Innovation Council Fund, GGroupe Etchart, IIRDI, LLurra Capital AG, NNACO
   Source: Business Wire
2. June 1, 2021
   Series B+ · $18.34M
   AAQUITI Gestion, BBroadview Ventures, DDoliam, GGalia Gestion, IIRDI, LLauak Group, MM Capital Partners, VVerve Ventures
   Source: infomeddnews.com
3. June 30, 2016
   Website created
4. March 22, 2016
   Series A · $7.19M
   BBroadview Ventures (lead), AAQUITI Gestion, GGalia Gestion, IIRDI, MM Capital Partners, SSofimac Investment Managers
   Source: finsmes.com

Founders and team

• AM
  Arnaud Mascarell CEO & CO-Founder

  LinkedIn · source: fineheart.fr
• PR
  Philippe Ritter Founder

  LinkedIn
• SG
  Stephane Garrigue Founder & Chief Scientific Offier

  LinkedIn · source: fineheart.fr
• SR
  Sebastien Robitaille CFO

Investors

• AAQUITI Gestion
• BBroadview Ventureslead investor
• DDoliam
• EEuropean Innovation Council Fund
• GGalia Gestion
• GGroupe Etchart
• GGroupe Pasteur Mutualitélead investor
• IImportant Projects of Common European Interest
• IIRDI
• LLauak Group
• LLurra Capital AG
• MM Capital Partners
• NNACO
• SSofimac Investment Managers
• VVerve Ventures

Companies like FineHeart

• KK2 Therapeutics$50M Seed · Aug 2026
• AAdcendo$75M Series B+ · Apr 2026
• AArnatar Therapeutics$50M Series A · Mar 2026
• JJucaBioSeries A · Sep 2025
• TTinkeso Therapeutics
• RRestore Medical$23M Series B+ · Jul 2025